8 recruiting. 8 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Recruiting 8 |
| Phase 2 | 2 | Recruiting 2 |
Follow Eczema: new trials by email Literature Review of Eczema trials Research Report on Eczema
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema Tilrekimig, Dupilumab, Placebo for Tilrekimig - Atopic Dermatitis | Phase 3 | Recruiting | Pfizer | 1375 | 2026-08-24 | 2026-10-22 |
| A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema Tilrekimig, Placebo - Atopic Dermatitis | Phase 3 | Recruiting | Pfizer | 375 | 2026-08-17 | 2026-10-15 |
| A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema Abrocitinib - Atopic Dermatitis | Phase 3 | Recruiting | Pfizer | 450 | 2025-12-02 | 2026-10-13 |
| A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema Abrocitinib, Placebo - Eczema | Phase 3 | Recruiting | Pfizer | 150 | 2025-07-24 | 2026-09-25 |
| A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema) GX-03, Vehicle - Eczema Atopic Dermatitis, Eczema | Phase 2 / Phase 3 | Recruiting | Turn Therapeutics | 190 | 2025-07-11 | 2026-09-04 |
| Herbal Ointment in Treating Atopic Dermatitis Topically herbal ointment, Placebo - Atopic Dermatitis, Atopic Dermatitis (AD) | Phase 2 / Phase 3 | Recruiting | En Chu Kong Hospital | 66 | 2025-03-01 | 2025-02-27 |
| VItamin D in pregnanCy for prevenTion Of eaRlY Childhood Asthma Cholecalciferol D3, Olive oil - Asthma, Respiratory Tract Infections | Phase 3 | Recruiting | Professor Klaus Bønnelykke | 2000 | 2024-12-20 | 2025-09-30 |
| Fish Oil in pREgnancY for Personalized Prevention of Early Childhood Asthma n-3 fatty acid, Rape seed oil - Asthma, Respiratory Tract Infections | Phase 3 | Recruiting | Professor Klaus Bønnelykke | 2000 | 2024-12-20 | 2025-09-30 |
Dermatitis, Atopic (5) · Dermatitis (3) · Skin Diseases (3) · Skin Diseases, Eczematous (3) · Skin Diseases, Genetic (3) · Asthma (2) · Croup (2) · Fractures, Bone (2) · Hypersensitivity (2) · Immune System Diseases (2) · Infections (2) · Mental Disorders (2) · Respiratory Sounds (2) · Respiratory Tract Infections (2)
Skin and Connective Tissue Diseases (8) · Hypersensitivity, Immediate (7) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5) · Dermatitis (5) · Genetic Diseases, Inborn (5) · Hypersensitivity (5) · Immune System Diseases (5) · Skin Diseases (5) · Skin Diseases, Eczematous (5) · Bronchial Diseases (2) · Laryngeal Diseases (2) · Laryngitis (2) · Lung Diseases (2) · Lung Diseases, Obstructive (2) · Otorhinolaryngologic Diseases (2)
abrocitinib (2) · Fatty Acids, Omega-3 (1) · Olive Oil (1) · dupilumab (1)
Pfizer (4) · Professor Klaus Bønnelykke (2) · En Chu Kong Hospital (1) · Turn Therapeutics (1)
United States (5) · Japan (4) · China (2) · Denmark (2) · Hungary (2) · Mexico (2) · Poland (2) · Spain (2) · Germany (1) · Taiwan (1)
Bo Chawes, PhD (2)
2023 (2)